Sustained Release Drug Delivery Systems Market was valued at USD 10.5 Billion in 2022 and is projected to reach USD 18.2 Billion by 2030, growing at a CAGR of 7.5% from 2024 to 2030.
By 2023, however, a shift in demand is anticipated, reflecting evolving patient needs and the growing adoption of personalized medicine. The demand for sustained release drug delivery systems is expected to increase even further as the global population ages and the burden of chronic diseases escalates. Additionally, innovations such as biodegradable polymers and advanced nanotechnology are expected to contribute to the growth of SRDDS by enabling more precise control over drug release. The growing focus on patient-centric therapies, with a shift towards oral drug delivery and convenient formulations, is likely to boost market growth in the coming years.
As the market moves toward 2033, several factors will shape the outlook of sustained release drug delivery systems. These include ongoing research in gene therapies, the development of drugs for previously untreatable conditions, and the need for more efficient drug administration methods. The combination of improved manufacturing techniques and more affordable solutions is likely to expand the reach of SRDDS across different demographics. Moreover, the pharmaceutical industry will likely focus on improving the cost-effectiveness of sustained release systems to cater to both developed and emerging markets.
Looking forward, the SRDDS market will be driven by new regulatory approvals, collaborations between drug manufacturers and tech companies, and a broader understanding of how to enhance drug absorption and bioavailability. The demand for SRDDS will not only be driven by the need for better patient outcomes but also by their ability to reduce healthcare costs in the long term. While the market has already seen substantial growth from 2018 to 2022, the future looks even brighter with increasing opportunities for innovation and market expansion.
Get an In-Depth Research Analysis of the Global Sustained Release Drug Delivery Systems Market Size And Forecast [2025-2032]
The sustained release drug delivery systems (SRDDS) market has experienced significant growth from 2018 to 2022, driven by advancements in pharmaceutical technologies, increased demand for chronic disease treatments, and the rising need for targeted therapies. Over this period, SRDDS provided significant improvements in drug efficacy and patient compliance, allowing drugs to be released at a controlled rate over an extended period. The technological innovations during this time have been key to creating more effective treatment options for conditions like diabetes, hypertension, and cancer. With increasing pressure to provide more patient-friendly therapies, the demand for SRDDS continues to grow, providing a promising outlook for the pharmaceutical sector.
West Pharmaceutical Services
Cirtec Medical
Balda
Lubrizol
Beckman Coulter
Scios
Noven Pharmaceuticals
Raritan Pharmaceuticals
Parker Hannifin
Nitto Avecia Pharma Services
KV Pharmaceutical
Equashield
Shire Laboratories
Powder Systems
B. Braun OEM Division
Pharmaco-Kinesis
Foresee
Bayer
Catalent
Pfizer
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Global Sustained Release Drug Delivery Systems Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Global Sustained Release Drug Delivery Systems Market
Hospitals
Clinics
Others
Based on Types the Market is categorized into Below types that held the largest Sustained Release Drug Delivery Systems market share In 2023.
Nonbiodegradable Implants
Biodegradable Implants
Micro- and Nano-Particles
Liposomes
ECT
Global (United States, Global and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Sustained Release Drug Delivery Systems Market Research Analysis
1. Introduction of the Global Sustained Release Drug Delivery Systems Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Global Sustained Release Drug Delivery Systems Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Global Sustained Release Drug Delivery Systems Market, By Type
6. Global Sustained Release Drug Delivery Systems Market, By Application
7. Global Sustained Release Drug Delivery Systems Market, By Geography
Global
Europe
Asia Pacific
Rest of the World
8. Global Sustained Release Drug Delivery Systems Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Global Research and Consulting firm servicing over 5000+ global clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/